A PHASE II TRIAL OF SALVAGE TREATMENT WITH GEMCITABINE AND S-1 COMBINATION IN HEAVILY PRETREATED PATIENTS WITH METASTATIC COLORECTAL CANCER

被引：0

作者：

Sym, S. J. ^{[1
]}

Hong, J. ^{[1
]}

Jung, M. ^{[1
]}

Park, J. ^{[1
]}

Cho, E. K. ^{[1
]}

Lee, J. H. ^{[1
]}

Lee, W. -S. ^{[2
]}

Baek, J. -H. ^{[2
]}

Shin, D. B. ^{[1
]}

机构：

[1] Gachon Univ, Gil Hosp, Div Hematol & Oncol, Dept Internal Med, Inchon, South Korea

[2] Gachon Univ, Gil Hosp, Dept Gen Surg, Inchon, South Korea

来源：

ANNALS OF ONCOLOGY | 2012年 / 23卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：151 / 152

页数：2

共 50 条

[21] Phase II trial of S-1 monotherapy in elderly or frail patients with metastatic colorectal cancer
Sang Joon Shin
Jae Heon Jeong
Young Suk Park
Kyung Hee Lee
Byoung Yong Shim
Tae Won Kim
Do Youn Oh
Myung Ah Lee
Yong Tai Kim
Yeul Hong Kim
Dae Young Zang
Jae Kyung Roh
Joong Bae Ahn
Investigational New Drugs, 2011, 29 : 1073 - 1080
[22] A Phase II study of S-1 plus oral leucovorin in heavily treated metastatic colorectal cancer patients
Hsu, Hung-Chih
Chou, Wen-Chi
Kuan, Feng-Che
Lee, Kuan-Der
Rau, Kun-Ming
Huang, En-Seng
Yang, Tsai-Sheng
CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 6061 - 6070
[23] Gemcitabine monotherapy as salvage chemotherapy in heavily pretreated metastatic breast cancer
Sun Young Rha
Yong Hwa Moon
Hei Chul Jeung
Yong Tae Kim
Joo Hyuk Sohn
Woo Ick Yang
Chang Ok Suh
Gwi Eon Kim
Jae Kyung Roh
Hyun Cheol Chung
Breast Cancer Research and Treatment, 2005, 90 : 215 - 221
[24] Gemcitabine monotherapy as salvage chemotherapy in heavily pretreated metastatic breast cancer
Rha, SU
Moon, YH
Jeung, HC
Kim, YT
Sohn, JH
Yang, WI
Suh, CO
Kim, GE
Roh, JK
Chung, HC
BREAST CANCER RESEARCH AND TREATMENT, 2005, 90 (03) : 215 - 221
[25] Biweekly gemcitabine and capecitabine in heavily pretreated patients with metastatic colorectal cancer (mCRC)
Solis Hernandez, Maria Del Pilar
Jimenez, Paula
Faez Garcia, Laura
Alvarez Fernandez, Carlos
Perez Arnillas, Quionia
Rodriguez Rubi, David Jose
Lucrecia Ruiz, Ana
Sanchez Lorenzo, Luisa
Li Torres, Walter Antonio
Uriol, Esther
Dolores, Maria
Prieto, Menendez
Maria Vieitez de Prado, Jose
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
[26] Phase II trial of gemcitabine and S-1 for patients with advanced pancreatic cancer
Hunho Song
Boram Han
Choong Kee Park
Jong Hyeok Kim
Jang Yong Jeon
In-Gyu Kim
Hyo Jung Kim
Joo Young Jung
Jung Han Kim
Jung Hye Kwon
Geundoo Jang
Ho Young Kim
Hyeong Su Kim
Dae Ro Choi
Dae Young Zang
Cancer Chemotherapy and Pharmacology, 2013, 72 : 845 - 852
[27] Phase II trial of gemcitabine and S-1 for patients with advanced pancreatic cancer
Song, Hunho
Han, Boram
Park, Choong Kee
Kim, Jong Hyeok
Jeon, Jang Yong
Kim, In-Gyu
Kim, Hyo Jung
Jung, Joo Young
Kim, Jung Han
Kwon, Jung Hye
Jang, Geundoo
Kim, Ho Young
Kim, Hyeong Su
Choi, Dae Ro
Zang, Dae Young
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 72 (04) : 845 - 852
[28] Phase II trial of S-1 in combination with gemcitabine for chemo-na⟨ve patients with locally advanced or metastatic pancreatic cancer
Lee, Gyeong-Won
Kim, Hye Jung
Ju, Ji-Hyun
Kim, Seok-Hyun
Kim, Hoon Gu
Kim, Tae Hyo
Kim, Hyun Jin
Jeong, Chi-Young
Kang, Jung Hun
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 64 (04) : 707 - 713
[29] Phase II trial of S-1 in combination with gemcitabine for chemo-naïve patients with locally advanced or metastatic pancreatic cancer
Gyeong-Won Lee
Hye Jung Kim
Ji-Hyun Ju
Seok-Hyun Kim
Hoon Gu Kim
Tae Hyo Kim
Hyun Jin Kim
Chi-Young Jeong
Jung Hun Kang
Cancer Chemotherapy and Pharmacology, 2009, 64
[30] Phase I/II study of sequential combination with irinotecan and S-1 in patients with metastatic colorectal cancer
Yoshioka, T.
Kato, S.
Gamoh, M.
Suzuki, T.
Shibata, H.
Shimodaira, H.
Otsuka, K.
Kakudo, Y.
Takahashi, S.
Ishioka, C.
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)

← 1 2 3 4 5 →